ILMNIllumina, Inc.
209.98USD+2.43%Mkt Cap: 30.95B $P/E: 38.18

Illumina, Inc. provides sequencing- and array-based solutions for genetic and genomic analysis in the Americas, Europe, Greater China, the Asia Pacific, the Middle East, and Africa. The company offers sequencing- and arr…

Key Statistics

Company
Market Cap30.95B $
Enterprise Value33.56B $
Revenue (TTM)4.49B $
Gross Profit2.87B $
Net Income (TTM)850.00M $
Revenue/Share29.57 USD
Last Price209.98 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees8.6K
CountryUS
SectorHealthcare
IndustryDiagnostics & Research
ISIN
Valuation
P/E (Trailing)38.18
P/E (Forward)34.98
PEG2.91
EV/EBITDA29.05
EV/Revenue7.47
P/S7.16
P/B11.35
EPS (TTM)5.57
EPS (Forward)6.10
52W Range
88.00100% of range207.00
52W High207.00 USD
52W Low88.00 USD
Profitability
Gross Margin66.08%
Oper. Margin21.14%
EBITDA Margin25.70%
Profit Margin19.57%
ROE31.22%
ROA12.79%
Growth
Revenue Growth9.40%
Earnings Growth-9.40%
Cash Flow & Leverage
Operating CF1.08B $
CapEx (TTM)148.00M $
FCF Margin17.75%
FCF Yield2.58%
Net Debt1.36B $
Net Debt/EBITDA1.18
Balance Sheet
Debt/Equity0.94
Current Ratio1.80
Quick Ratio1.25
Book Value/Sh18.80 USD
Cash/Share7.735 USD
Dividends
Fwd Div Rate
Trail. Div Rate0.0000 USD
Div. Yield
5Y Avg Yield
Payout Ratio0.00%
Ex-Div Date
Pay Date
Splits
Last Split1028:1000
Split DateJun 25, 2024
Analyst Consensus
Rating2.5 (Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)198.89 USD
Upside (mean)-5.3%
Target Range113.00 USD230.00 USD
$113.00-5.3% to mean$230.00
# Analysts19
Ownership
Shares Out.151.00M
Float148.48M
Insiders0.20%
Institutions105.91%
Short Interest
Short Ratio4.2d
Short % Float8.73%
Short % Out.5.34%
Shares Short8.06M
Short (prev mo.)7.57M
Technical
SMA 50186.40 (+12.6%)
SMA 200146.47 (+43.4%)
Beta1.46
S&P 52W Chg18.16%
Avg Vol (30d)1.82M
Avg Vol (10d)1.53M
Technical Indicators
RSI (14)63.0
MACD3.0615
MACD Signal3.7011
MACD Hist.-0.6396
BB Upper206.30 USD
BB Middle195.56 USD
BB Lower184.82 USD
BB Width10.98%
ATR (14)7.568 USD
Vol Ratio (20d)1.09x